Compounded drugs can involve dosing errors
Partial unilateral lentiginosis, as reported by Jindal et al
Retatrutide covers GLP-1, GIP, and glucagon receptors
This increase is observed in several diseases including congenital deficits in urea cycle enzymes, Reyes syndrome in children, uraemic encephalopathy, diabetic encephalopathy, or hypoglycaemic encephalopathy, although the most frequent cause for hyperammonaemia is associated with acute (due to poisons or drugs) and chronic (cirrhosis) liver failure
However, there is no clinical evidence or regulatory guidance supporting the combined use of Lipo C with retatrutide, and this combination should not be used outside approved clinical trials
Introduce the combination gradually start with GHK-Cu to establish barrier resilience, then add tretinoin at low frequency and titrate up